However, little is known about the alterations of glycoproteins glycosylation in serum from patients with ASD compared to the healthy volunteers, which might be significant for finding novel biomarkers, pathogenesis, and therapeutic strategies in ASD.
← all excerpts
Serum glycopattern and Maackia amurensis lectin-II binding glycoproteins in autism spectrum disorder.
1
—
—